A C-peptide test measures the amount of C-peptide, a short protein produced by the pancreas, in the blood. Learn how the procedure and results can help to manage diabetes.

Background: Connecting peptide (C-peptide) plays a role in early atherogenesis in patients with diabetes mellitus and may be a marker for cardiovascular morbidity and mortality in patients without ...

High levels of c-peptide with a low level of blood glucose could be an indication of insulin resistance, either type 2 diabetes or Cushing’s syndrome. High levels of c-peptide but low blood glucose ...

What is the role of C peptide in managing uncontrolled type 2 diabetes?—Ndukwe H. Odeluga, MD, Bakersfield, Calif. Cleaved from proinsulin to make mature ...

Some patients who have had type 1 diabetes for decades can still produce C-peptide and respond to hyperglycemia, suggesting residual β-cell function. Menu SECTIONS Home ...

Although ‘lean type 2 diabetes’ is not uncommon, clinicians must first exclude other causes including autoimmune, monogenic, ...

Is there any role for C-peptide in the management of type 2 diabetes mellitus? — VICKIE LANDRETH, RN, MSN, FNP, Lyons, Colo. Neither the American Diabetes Association nor the American ...

C-peptide test can help in the correct diagnosis and treatment of diabetes. This simple and cheap test can differentiate between Type-1 and Type-2 diabetes, as well as other genetic forms of diabetes.

Using a more convenient, cheaper C-peptide test a few years after diagnosis of type 1 diabetes can help pinpoint occasional patients who have been misdiagnosed. News & Perspective Drugs & Diseases ...

C-peptide is able to stratify response to an expensive therapy in insulin-treated diabetes meaning the test can identify individuals who will not benefit from this drug.

Once-daily oral verapamil may help preserve stimulated C-peptide secretion for children and adolescents with type 1 diabetes, according to a study published in JAMA. In findings from a randomized ...

Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with ...